Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacogenomics: integration into drug discovery and development.

Keith Johnson1, John Thompson, Aidan Power

  • 1Clinical Pharmacogenomics, Pfizer Global Research and Development, Ann Arbor, Michigan, USA.

Current Topics in Medicinal Chemistry
|September 27, 2005
PubMed
Summary

Integrating pharmacogenomics into medicine development is key for personalized treatments. This approach requires new skills and infrastructure, but offers significant success despite challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Features predicting data exclusion in imaging studies of Alzheimer's disease.

Alzheimer's & dementia (Amsterdam, Netherlands)·2026
Same author

3D printing monolithic, multifunctional polymer acoustofluidic devices with tunable mixing and particle focusing.

Lab on a chip·2026
Same author

Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial.

Nature medicine·2026
Same author

Postpartum readmission for maternal infection or neonatal adverse events in women randomised to outpatient balloon versus inpatient prostaglandin for induction of labour: a post-trial follow up study.

BMC pregnancy and childbirth·2026
Same author

Bayesian modelling demonstrates clinically relevant heterogeneity in Tau PET patterns in Alzheimer's disease.

European journal of nuclear medicine and molecular imaging·2026
Same author

Amyloid Imaging and APOE Genotype Disclosure and Short-Term Psychological Distress.

JAMA network open·2026

Area of Science:

  • Pharmacogenomics and Drug Development
  • Personalized Medicine
  • Genetics in Pharmaceuticals

Background:

  • Personalized medicine relies on integrating pharmacogenomics into drug discovery and development.
  • The pharmaceutical industry is investing in resources for this integration.
  • Traditional industry skill sets, capabilities, and infrastructures need adaptation.

Purpose of the Study:

  • To describe the successful integration of genetics and pharmacogenomics data in medicine.
  • To illustrate the challenges posed by new pharmacogenomic science and technologies.
  • To propose solutions for addressing these challenges to fulfill the promise of personalized medicine.

Main Methods:

  • Review of current industry practices in integrating genetics and pharmacogenomics data.

Related Experiment Videos

  • Analysis of successes achieved through data integration.
  • Identification and discussion of challenges in adopting new scientific and technological approaches.

    • Main Results:

    • Demonstrated success in delivering personalized medicine through genetics and pharmacogenomics integration.
    • Highlighted challenges including skill gaps, infrastructure needs, and technological hurdles.
    • Provided strategies for overcoming these obstacles.

    Conclusions:

    • Successful integration of pharmacogenomics is crucial for advancing personalized medicine.
    • Addressing the associated challenges requires strategic investment in skills and infrastructure.
    • Overcoming these hurdles will enable the full realization of personalized medicine's potential.